IL10 and type 1 diabetes mellitus: Nonetheless, as discussed earlier, circulating IL-10 producing, antigen-specific CD4 T cells have been observed post-intra-dermal peptide administration in studies in T1D patients and this mode of action remains a major focus of attention.